© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 30MCG/0.3ML 3RD | Medium Descr | IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 3RD DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | CR | Catastrophe/disaster related | GW | Service not related to the hospice patient's terminal condition | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2025-01-01 | Note | First appearance of code deletion in codebook. |
| 2024-01-01 | Note | First appearance of 2022 guideline updates in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-05-01 | Note | Changes made to dosing information. |
| 2023-04-18 | Note | These codes (previously associated with 0003A) are no longer authorized for use in the United States: 91300, 91305, 91307, 91308. |
| 2023-04-18 | Note | 0003A No longer authorized for use in the United States. |
| 2023-01-01 | Added | First appearance in codebook. |
| 2023-01-01 | Changed | Code description changed. |
| 2023-01-01 | Note | First appearance of guideline change(s) in codebook. |
| 2022-12-08 | Note | AMA guideline changed to include 91317. Published to website 2021-12-09. Received FDA approval effective retroactively to 2022-12-08. |
| 2022-10-12 | Note | AMA Guideline changed. 91315 received FDA approval. |
| 2022-08-31 | Note | AMA Guideline changed. 91312 received FDA approval effective immediately. |
| 2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age to (12+). |
| 2022-06-17 | Note | AMA Guideline changed. 91308 received FDA approval. |
| 2022-02-01 | Note | AMA guideline changed to include 91308 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2021-10-29 | Note | AMA Guideline changed. 91305, 91307 received FDA approval. |
| 2021-10-06 | Note | AMA guideline changed to include 91307 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2021-09-22 | Note | AMA Guideline changed. 0004A received FDA approval. |
| 2021-09-03 | Note | AMA guideline changed to include 0004A, 91305 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2021-09-03 | Note | AMA guidelines added to include 0001A, 0002A, 91300. These codes were published to AMA website and received FDA approval prior to addition of the guideline. |
| 2021-08-12 | Added | FDA approval received |
| 2021-07-30 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |